| Featured Articles |
 |
Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries
Reuters | July 9, 2025
|
|
FDA approves twice-yearly capsid inhibitor for HIV prevention
Nature | July 8, 2025
|
|
Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the...
HIV.gov | June 12, 2025
|
|
If Twice-Yearly Lenacapavir Could Be a HIV PrEP Game Changer, Would a Once-Yearly Version Be a HIV Epidemic Ender?
Managed Healthcare Executive | March 13, 2025
|
|
ViiV Healthcare announces new implementation study data showing zero cases of HIV with apretude, the only long-acting injectable approved for...
ViiV Healthcare | March 12, 2025 |
|
Gilead data suggests once-yearly shot of PrEP drug blocks HIV infection
STAT News | March 11, 2025
|
|
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Gilead | February 18, 2025
|
|
This is what happens to the body when HIV drugs are stopped for millions of people
AP | February 13, 2025
|
| |
|
|
| News Updates |
|
Viiv Healthcare Presents New Data Demonstrating Positive Real-World Impact of Its Innovative Long-Acting Injectables for HIV at IAS 2025
ViiV | July 8, 2025
|
|
The Drug That Could Revolutionize the Fight Against H.I.V.
The New Yorker | June 24, 2025
|
|
Yeztugo® (Lenacapavir) Is Now the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
Gilead | June 18, 2025
|
|
FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention
Contagion Live | June 18, 2025
|
|
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
The Guardian | June 17, 2025
|
|
FDA Alert: Infectious Diseases Drug News Roundup
ISA | June 13, 2025
|
|
Gilead hit with FDA clinical hold for batch of HIV trials
Yahoo | June 11, 2025
|
|
Affordable HIV drug shows promise in improving vision for diabetic eye disease
News-Medical | May 27, 2205
|
|
HIV drug can improve vision in patients with common diabetes complication
NIH | May 27, 2025
|
|
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
IDA | May 21, 2025
|
|
Certain HIV Meds Linked to Reduced Alzheimer’s Risk
Medscape | May 16, 2025
|
|
Expanding HIV Prevention: Overcoming Barriers and Embracing Long-Acting PrEP
Contagion Live | May 16, 2025
|
|
Alzheimer's disease could be prevented by antiviral drug already on market
Fox News | May 15, 2025
|
|
Gilead Sciences to Pay $202 Million in US Settlement Over HIV Drug Kickbacks
US News & World Report | April 29, 2025
|
|
Unhealthy Alcohol Use and HIV Preexposure Prophylaxis—Opportunities for Integrated Care
JAMA | April 25, 2025
|
|
Real-World Evidence Supports DTG+3TC for ART in Diverse HIV Populations
IDA | April 25, 2025
|
|
Gilead posts profit, says HIV prevention drug on track for mid-June
Reuters | April 24, 2025
|
|
IL plan to remove prior authorization from some HIV drugs passes the House
News 25 Illinois | April 14, 2025
|
|
Manufacturer’s plans for equitable access to twice-yearly PrEP under fire
Aidsmap | April 10, 2025
|
|
HIV testing requirements must be simplified for injectable PrEP to have a future
Aidsmap | March 21, 2025
|
| |
|
|
